Evidence map›Paper›PMID 40637729›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2025

Multicenter multiplatform pattern-of-practice analysis of single-isocenter multitarget stereotactic radiosurgery.

Benedikt Thomann, Tobias Fechter, Johannes Fischer, Armin Runz, Julian Roers, Ute Ludwig, Melanie Grehn, Maximilian Grohmann, Christian Ziemann, Michael Judge and 27 more

Abstract readMulticenter Study
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Benedikt ThomannKlinik für Strahlenheilkunde, Abteilung Medizinische Physik, Universitätsklinikum Freiburg, Freiburg, Germany. benedikt.thomann@uniklinik-freiburg.de.ORCID 0009-0002-1617-2483
Tobias FechterKlinik für Strahlenheilkunde, Abteilung Medizinische Physik, Universitätsklinikum Freiburg, Freiburg, Germany.
Johannes FischerMedizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Armin RunzAbteilung Medizinische Physik in der Strahlentherapie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Julian RoersKlinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Münster, Münster, Germany.
Ute LudwigMedizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Melanie GrehnKlinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Maximilian GrohmannKlinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Christian ZiemannKlinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Lübeck, Germany.
Michael JudgeKlinik und Poliklinik für Radioonkologie, Cyberknife- und Strahlentherapie, Uniklinik Köln, Köln, Germany.
Wolfgang BausStrahlentherapie, Wege Klinik Bonn, Bonn, Germany.
Michelle GrahleStrahlentherapie, Medizinische Physik, Städtisches Klinikum Dresden, Dresden, Germany.
Matthias WalkeMedizinische Physik, Universitätsklinik für Strahlentherapie Magdeburg, Magdeburg, Germany.
Bastian BathenSaphir Radiochirurgie Zentrum Frankfurt am Main und Norddeutschland, Kiel, Germany.
Janett KöhnSaphir Radiochirurgie Zentrum Frankfurt am Main und Norddeutschland, Kiel, Germany.
Paul KäthnerKlinik und Poliklinik für Strahlentherapie und Radioonkologie, Uniklinikum Würzburg, Würzburg, Germany.
Maya ShariffKlinik für Radioonkologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Rebecca MatthisKlinik für Strahlentherapie und Radioonkologie, Medizinische Physik, Klinikum Stuttgart, Stuttgart, Germany.
Jens FleckensteinKlinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Mannheim, Mannheim, Germany.
Sascha GroßmannKlinik und Poliklinik für Radioonkologie und Strahlentherapie, Universitätsmedizin Mainz, Mainz, Germany.
Tino StrellerRadioonkologie, Medizinphysik, Luzerner Kantonsspital, Luzern, Switzerland.
Simon HowitzStrahlentherapie und Radioonkologie, SRH Wald-Klinikum Gera, Gera, Germany.
Marlen PriegnitzKlinik für Radioonkologie und Strahlentherapie, Medizinische Universität Lausitz-Carl Thiem, Cottbus, Germany.
Rocco WeigelUniversitätsklinik für Strahlentherapie und Radioonkologie, Tirol Kliniken, Innsbruck, Austria.
Peter WinklerAbteilung für Therapeutische Radiologie und Onkologie, Medizinische Universität Graz, Graz, Austria.
Oliver BlanckKlinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Kiel, Germany.
Daniela SchmittKlinik für Strahlentherapie und Radioonkologie, Universitätsmedizin Göttingen, Göttingen, Germany.
Jurgen BeckKlinik für Neurochirurgie, Universitätsklinikum Freiburg, Freiburg, Germany.
Marcia MacheinKlinik für Neurochirurgie, Universitätsklinikum Freiburg, Freiburg, Germany.
Evangelos PappasDepartment of Biomedical Sciences, Radiology and Radiotherapy Sector, University of West Attica, Athens, Greece.
Ilinca PoppMedizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Michael ReinerStrahlentherapie und Radioonkologie, Medizinische Physik, LMU Klinikum München, München, Germany.
Christian P KargerAbteilung Medizinische Physik in der Strahlentherapie, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Christos MoustakisKlinik und Poliklinik für Strahlentherapie, Medizinische Physik, Universitätsklinikum Leipzig, Leipzig, Germany.
Michael BockMedizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Anca-Ligia GrosuMedizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Dimos BaltasKlinik für Strahlenheilkunde, Abteilung Medizinische Physik, Universitätsklinikum Freiburg, Freiburg, Germany.

Funding

Deutsche Krebshilfe 701143317
6 · The paper itself

Abstract

purposeSingle-isocenter multitarget stereotactic radiosurgery (SIMT SRS) offers enhanced clinical efficiency for treating multiple brain metastases. However, it introduces additional uncertainties, such as off-center dose and beam profile inaccuracies, as well as quality assurance (QA) challenges, complicating its implementation. This study aims to evaluate different SIMT SRS approaches.

methodsWe collected and analyzed SIMT SRS protocol and infrastructure parameters from 23 radiotherapy centers across Germany, Austria, and Switzerland, encompassing immobilization systems, computed tomography (CT) protocols, linear accelerators, treatment planning systems, beam configurations, imaging techniques, and QA practices. Consensus, deviations, and compliance with current guidelines were assessed. Subsequent studies will include on-site measurements, evaluation of treatment plan quality and delivery accuracy, and correlation of these findings with the analyzed protocols to identify potential links between protocol parameters and clinical outcomes.

resultsThere is consensus (at least 80% agreement) for a CT slice thickness of ≤ 1 mm, the need for six-degree-of-freedom patient setup correction, and noncoplanar treatment. There is notable variability for intrafraction imaging (used by 70%), minimum accepted planning target volume diameter (ranging from 2-10 mm), SRS QA, and general plan parameters, such as photon energy and number of treatment fields. There is also high variability in employed linear accelerator models and treatment planning systems.

conclusionThese findings highlight a lack of standardization in SIMT SRS practices. Combined with future measurements correlating protocols to treatment quality, our study will provide a foundation for recommendations to support the safe and standardized implementation of SIMT SRS.

Indexed as

Brain NeoplasmsPractice Patterns, Physicians'RadiosurgeryAustriaGermanyHumansParticle AcceleratorsQuality Assurance, Health CareRadiotherapy DosageRadiotherapy Planning, Computer-AssistedSwitzerlandTomography, X-Ray ComputedAnthropomorphic phantomBrain metastasesEnd-to-end testRing trialSIMT SRS

Identifiers

PMID40637729
PMCPMC12373538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.